https://www.selleckchem.com/products/WP1130.html
188, 95% confidence interval [CI], 1.405-27.244, p=0.018; OR, 9.722, 95% CI, 1.614-58.581, p=0.013; and OR, 21.750, 95% CI, 4.016-117.783, p0.001, respectively). Multivariate analysis revealed that not achieving PR until 12months was an independent prognostic factor predicting failure to CR after prolonged progestin therapy (OR, 21.803, 95% CI, 3.601-132.025, p=0.001). Continued medical treatment is effective for persistent early endometrial carcinoma after at least 9months of progestin therapy in young women who want to preserve the
Like
Comment
Share
